Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Curr Med Chem. 2016;23(18):1818–1869. doi: 10.2174/0929867323666160418114826

Table 6.

Reports of BCRP transporter sensitivity for some PET radioligands in various species, based on in vitro assays and on in vivo, mainly PET, studies.

Radioligand Imaging target In vivo species In vitro species Substrate (Yes/No) Reference
[18F]MPPF 5-HT1A M (g) No [194]
[18F]MPPF 5-HT1A H (c) No [197]
[11C]WAY 5-HT1A H (c) No [197]
[11C]PIB Aβ H (c) No [197]
[11C]Flumazenil Bz H (c) No [197]
[18F]Fallypride D2/D3 H (c) No [197]
[11C]Raclopride D2/D3 H (c) No [197]
[11C]Befloxatone MAO-A R (g) No [205]
[11C]Befloxatone MAO-A H (c) Yes [197]
[11C]PK11195 TSPO H (c) No [197]

M = Mouse, R = Rat; H = Human.

c = cell-based assay; g = efflux transporter knockout.